Normand Blais, BIOVECTRA’s Senior Director, Development & Innovation, Biologics, provides strategic scientific guidance to BIOVECTRA’s mRNA and pDNA programs. He is accomplished in early candidate vaccine development and has considerable leadership experience in vaccine research and development and expertise in mRNA platforms. His key areas of expertise are vaccinology and technical development of biologics, vaccine design and scientific evidence generation, protein engineering and structural biology, and leveraging and interpreting protein biophysical characterization and analytics.